Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Theravance Biopharma
TBPH
$874M
| $274K | ﹤0.01% |
28,624
-65,785
| -70% | -$645K |
|
3127
Amneal Pharmaceuticals
AMRX
$5.85B
| $273K | ﹤0.01% |
65,745
-119,278
| -64% | -$528K |
|
3128
Taysha Gene Therapies
TSHA
$1.68B
| $273K | ﹤0.01% |
+44,387
| New | +$332K |
|
3129
Holley
HLLY
$321M
| $270K | ﹤0.01% |
+19,350
| New | +$248K |
|
3130
Personalis
PSNL
$1.35B
| $270K | ﹤0.01% |
32,999
-37,709
| -53% | -$390K |
|
3131
Red Robin
RRGB
$145M
| $270K | ﹤0.01% |
15,964
-11,946
| -43% | -$193K |
|
3132
Safe Bulkers
SB
$795M
| $270K | ﹤0.01% |
56,668
-75,165
| -57% | -$307K |
|
3133
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.89B
| $268K | ﹤0.01% |
3,956
+738
| +23% | +$49K |
|
3134
Solid Power
SLDP
$463M
| $268K | ﹤0.01% |
+30,867
| New | +$240K |
|
|
FNA
3135
DELISTED
Paragon 28, Inc.
FNA
| $267K | ﹤0.01% |
+15,930
| New | +$256K |
|
|
FSTX
3136
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $267K | ﹤0.01% |
+75,190
| New | +$278K |
|
|
ATAQ.U
3137
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
| $267K | ﹤0.01% |
+27,127
| New | +$269K |
|
|
CGC
3138
PUT
Canopy Growth
CGC
$387M
| $266K | ﹤0.01% |
3,520
-14,260
| -80% | -$1.09M |
|
3139
First Advantage
FA
$3.4B
| $266K | ﹤0.01% |
+13,186
| New | +$227K |
|
3140
TFS Financial
TFSL
$5.16B
| $266K | ﹤0.01% |
16,025
-3,987
| -20% | -$68.6K |
|
3141
Alector
ALEC
$168M
| $265K | ﹤0.01% |
18,563
-91,358
| -83% | -$1.44M |
|
|
YSG
3142
Yatsen Holding
YSG
$322M
| $264K | ﹤0.01% |
+77,091
| New | +$516K |
|
3143
BrightView Holdings
BV
$1.22B
| $262K | ﹤0.01% |
19,265
-49,129
| -72% | -$664K |
|
3144
ProShares UltraShort QQQ
QID
$282M
| $262K | ﹤0.01% |
+3,000
| New | +$285K |
|
3145
Dynagas LNG Partners
DLNG
$132M
| $260K | ﹤0.01% |
64,800
| – | – |
|
|
CLBTW
3146
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $260K | ﹤0.01% |
+204,615
| New | +$258K |
|
|
VISN
3147
Vistance Networks Inc
VISN
$2.65B
| $259K | ﹤0.01% |
33,187
+16,850
| +103% | +$154K |
|
3148
Agilon Health
AGL
$1.53B
| $258K | ﹤0.01% |
+406
| New | +$209K |
|
3149
Cogent Biosciences
COGT
$6.65B
| $257K | ﹤0.01% |
+34,142
| New | +$238K |
|
3150
EverQuote
EVER
$892M
| $257K | ﹤0.01% |
15,884
-27,926
| -64% | -$423K |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.